Position in SRPT
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$1,328,665
+$68,777 QoQ
Shares Held
61,060
+4.3% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Sigma Planning Corp holds $10,800,162 across 16 Biotechnology names. SRPT ranks #4 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
7,297 | $1,669,042 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,012 | $1,554,551 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
20,592 | $1,330,860 | |
| 4 | SRPT |
Sarepta Therapeutics, Inc.
This page
|
61,060 | $1,328,665 | |
| 5 | MRNA |
Moderna, Inc.
|
25,705 | $1,305,814 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
4,500 | $898,425 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,062 | $474,225 | |
| 8 | RNTX |
Rein Therapeutics, Inc.
|
348,677 | $453,280 |
All Filings in SRPT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,328,665 | 61,060 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,259,888 | 58,545 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $428,680 | 22,246 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $414,350 | 24,231 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $588,356 | 9,219 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $1,281,558 | 10,540 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $1,354,931 | 10,849 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,770,390 | 11,205 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $1,602,067 | 12,375 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $502,689 | 5,213 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $1,503,734 | 12,405 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $1,386,264 | 12,105 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $1,683,455 | 12,214 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $1,659,142 | 12,804 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $1,424,418 | 12,886 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,005,063 | 13,408 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,066,338 | 13,650 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $1,240,889 | 13,780 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $1,254,028 | 13,560 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $1,051,044 | 13,520 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,084,262 | 14,548 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $2,511,147 | 14,729 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $2,082,576 | 14,830 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $2,400,770 | 14,973 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $2,062,534 | 21,085 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||